Featured Events
Join us for the upcoming PMI Stakeholder Briefing on 5 February 2026 at The Address Hotel, proudly supported by Salutem Insights. The event will feature Linda Fitzharris, Head of the Corporate Pharmaceutical Unit (CPU), who will share insights into the processes that underpin medicine pricing and reimbursement across the national health schemes, followed by an opportunity for Q&A.
Our Managing Director, Sandra Redmond, will open the session, bringing Salutem’s deep expertise in the Irish reimbursement landscape, HTA, and market access strategy.
This focused briefing provides industry stakeholders with practical updates on pricing, reimbursement, and policy developments in Ireland.
📍 Event Details:
Date: Thursday, 5 February 2026
Time: 8:00am – 10:00am
Venue: The Address Hotel, Dublin
Further Details & Booking: https://thepmi.com/events/
Stay ahead in the changing market access and reimbursement landscape by joining this timely and highly relevant industry update.
Date(s) - February 5, 2026
8:00 am - 10:00 am
Categories
Date(s) - November 20, 2025
7:30 am - 9:30 am
Categories
ISPOR Europe 2025, is taking place from 9–12 November 2025 in Glasgow, Scotland.
This year’s theme, “Powering Value and Access Through Patient-Centered Collaboration,” highlights the importance of strengthening partnerships across the healthcare ecosystem to accelerate patient-centered decision-making on healthcare value and access.
The conference will bring together experts from across Europe to explore how real-world evidence, pricing, reimbursement, and market access strategies can drive more equitable, sustainable, and impactful healthcare solutions.
Salutem Insights at ISPOR Europe 2025
We’re proud to announce that Salutem Insights will be presenting multiple posters at ISPOR Europe 2025. These projects reflect ongoing research, strong collaboration with leading international experts, and the depth of our in-house expertise in health economics and outcomes research (HEOR).
Poster Titles:
1️⃣ The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review — Raymond H. Henderson, Sandra Redmond, Colin Davenport, Órla Walsh, Séan Fennessy, Donal O’Shea
2️⃣ Barriers to Reimbursement: Characteristics of Unfunded Medicines in Ireland (2006–2021) — Sandra Redmond and Win Bo
3️⃣ Characterising Medicines Reimbursed under Managed Access Protocols in Ireland (2006–2025) — Sandra Redmond and Win Bo
4️⃣ Early Impact of the Mazars Review on Reimbursement Timelines in Ireland — Sandra Redmond and Win Bo
We’re also delighted that Dr. Raymond Henderson, Senior HTA Consultant at Salutem Insights, will receive an ISPOR Service Award for his outstanding contribution as Co-Chair of the Open Source Models Special Interest Group.
If you’re attending ISPOR Europe 2025, we’d love to connect — visit our LinkedIn page for updates from the event.
Date(s) - November 9, 2025 - November 12, 2025
All Day
Categories
Join IQVIA and Salutem Insights for a breakfast briefing on Real World Evidence in Market Access — exploring how RWE is transforming access pathways for obesity, orphan, and oncology medicines.
On Wednesday, 8 October 2025, Sandra Redmond, Managing Director at Salutem Insights, and Gwynne Morley, General Manager at IQVIA Ireland, will lead an in-person session at the Clayton Hotel Liffey Valley, Dublin.
The discussion will highlight how real world evidence is increasingly critical to securing reimbursement and shaping market access strategies. By going beyond clinical trial data, RWE can address payer expectations, demonstrate value, and support more equitable healthcare delivery.
Key themes include:
-
Obesity medicines: leveraging real world outcomes to accelerate access in a fast-moving therapeutic area.
-
Orphan medicines: tackling the evidence challenges of rare diseases with small patient populations.
-
Oncology medicines: showing how data-driven insights are reshaping reimbursement pathways in one of the most competitive therapy areas.
-
Strategic partnerships: how collaboration between consultancies and life sciences companies drives actionable evidence.
This event is designed for professionals involved in pricing, reimbursement, policy, and market access who want practical insights into applying RWE to optimise strategy.
📅 Date: Wednesday, 8 October 2025
🕗 Time: 08:00 – 09:30 BST
📍 Venue: Clayton Hotel, Liffey Valley, Dublin
👉 Register now to secure your place: Book Here
Date(s) - October 8, 2025
8:00 am - 9:30 am
Categories
Join us for a high-impact one-day masterclass focused on Market Access and Reimbursement in Ireland and the EU. Organised by the Pharmaceutical Managers Institute and proudly supported by Salutem Insights, this session brings together leading speakers from Irish health agencies, global consultancies, and the pharmaceutical industry.
As EU HTA becomes a central pillar of European market access strategy, this Masterclass offers timely insights. You’ll hear real-world examples, explore case studies, and learn how to navigate critical reimbursement challenges.
The event is designed for professionals working in or alongside market access roles who want to deepen their understanding of HTAs, reimbursement strategy, and policy implementation.
🎤 Confirmed Speakers Include:
-
Sandra Redmond, MD – Salutem Insights
-
Claire Barry, Head of Consulting – Salutem Insights
-
Bernard Duggan, Chief Pharmacist – HSE MMP
-
Stephanie Stengel, Ecker & Ecker GmbH (Germany)
-
Marian Hernon, Health Economics Manager – Amgen
With EU HTA changes on the horizon and Irish reimbursement processes evolving, this masterclass offers the latest insights, practical examples, and peer exchange — ideal for shaping future strategy.
Book today via the PMI: https://thepmi.com/events/
Date(s) - September 11, 2025
9:30 am - 4:30 pm
Categories
